Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | MIRM Mirum Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $89.70 +0.4% | $14.86 -2.5% |
| StockIQ Score | 44D Weak Risk: Medium | 36F Weak Risk: Medium |
| Technical | 9F | 13F |
| Fundamental | 35F | 35F |
| Growth | 82A- | 50C- |
| Fair Value | 38F | 38F |
| News | 86A | 50C- |
| Quality | 58C | 50C- |
| Risk | 48D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Mirum Pharmaceuticals (MIRM) outperforms Ascentage Pharma (AAPG) in most categories. Its investor score (51 vs. 37) and growth score (82 vs. 50) are significantly higher, showing stronger investor confidence and growth potential. However, AAPG matches MIRM in valuation (38 vs. 38), while MIRM leads in technical (42 vs. 18) and fundamental (30 vs. 35) scores. MIRM’s overall rating is also stronger at "Moderate" compared to AAPG’s "Weak."
